Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CREHA: Steroid + Cyclophosphamide vs Steroid + Rituximab in Acquired Haemophilia
NCT01808911Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- May 2012
- Primary completion
- Jan 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in acquired hemophilia (AH), sponsored by Rouen University Hospital. Started May 2012; status: completed.
02
Drugs
rituximab
03
Conditions
acquired hemophilia (AH)
Beyond the preview
Go deeper on NCT01808911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01808911.